Single residue measurements provide snapshot data yet sterilization validation and shelf-life studies demand understanding how residues decrease over time - dissipation kinetics determine aeration requirements and support shelf-life claims. Additional ethylene oxide/ethylene chlorohydrin extraction extends residual analysis through multiple cycles generating comprehensive dissipation data modeling residue depletion kinetics. Each extraction represents continued clinical exposure or extended aeration time, building curves that model residue depletion over device lifetime or storage duration. This extended analysis supports shelf-life validation demonstrating residues continue decreasing during storage enabling reduced aeration with aging, demonstrates aeration effectiveness showing time-dependent residue reduction validating aeration protocols, and provides data for devices with extended body contact requiring multiple extraction cycles per ISO 10993-7. For implantable devices with multi-year intended use, serial extractions demonstrate that residues deplete to negligible levels over implantation duration, supporting safety claims based on cumulative exposure rather than initial levels. The dissipation curve enables calculation of effective half-life for residue removal, optimizing aeration duration balancing rapid product release against adequate patient protection. Manufacturing investigations benefit from dissipation profiling revealing whether unexpected residue levels result from inadequate aeration or excessive EtO absorption requiring process modifications. For packaging validation, serial extraction demonstrates packaging doesn't trap residues preventing dissipation, or alternatively shows packaging effectiveness maintaining low residues during distribution.